Argos Therapeutics to Present at the Annual Sachs Immuno-Oncology: BD&L and Investment Forum

By: via Benzinga
Argos Therapeutics Inc. (Nasdaq: ARGS) ("Argos"), an immuno-oncology company focused on the development and commercialization of fully ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.